Novosteo Inc. — Form D/A
Novosteo Inc. of WEST LAFAYETTE, IN, a company, filed a Form D amendment with the SEC on 2022-04-21. The offering totals $17.7M, of which $17.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-04-21
- Form: D/A
- Accession: 0001840600-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $17.7M
- Amount sold: $17.7M
- Investors: 37
- Date of first sale: 2020-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386400
Issuer
- Name: Novosteo Inc.
- CIK: 0001840600
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1281 WIN HENTSCHEL BLVD., WEST LAFAYETTE, IN, 47906
- Phone: 765-761-3912
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Alex S Andrianopoulos | Director | West Lafayette, IN |
| Daniel S Hasler | Director | West Lafayette, IN |
| David J Lamond | Director | West Lafayette, IN |
| Philip S Low, Ph.D. | Director | West Lafayette, IN |
| William J Rutter | Director | San Francisco, CA |
| Dirk Thye, M.D. | Director | West Lafayette, IN |
| Philip S Low, Ph.D. | Executive Officer | West Lafayette, IN |
| Dirk Thye, M.D. | Executive Officer | West Lafayette, IN |
| Martin S Brena, Ph.D. | Director | West Lafayette, IN |
| William J Boyle, Ph.D. | Director | West Lafayette, IN |
| William J Boyle, Ph.D. | Executive Officer | West Lafayette, IN |
| Stewart A Low, Ph.D. | Executive Officer | West Lafayette, IN |
| Pascal S Krotee | Director | West Lafayette, IN |
| Dan S Hasler | Director | West Lafayette, IN |
Other filings by this issuer (3)
More